NYSE · LFVN
Consumer Defensive · Packaged Foods
$6.35
Up+$0.15 (+2.42%)
Updated Sep 21, 2026, 2:50 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
LFVN closed at $6.35 after 19 trading sessions, down 7.16% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $6.31 | $6.5399 | $6.14 | $6.35 | 51.03K |
| Sep 17, 2026 | $6.295 | $6.3799 | $6.13 | $6.20 | 22.27K |
| Sep 16, 2026 | $6.30 | $6.3759 | $6.15 | $6.18 | 36.89K |
| Sep 15, 2026 | $6.25 | $6.32 | $6.1257 | $6.18 | 28.4K |
| Sep 14, 2026 | $6.09 | $6.308 | $6.09 | $6.25 | 41.09K |
| Sep 11, 2026 | $6.35 | $6.66 | $5.99 | $6.17 | 72.73K |
| Sep 10, 2026 | $6.57 | $6.58 | $6.2616 | $6.37 | 30.27K |
| Sep 9, 2026 | $6.34 | $6.69 | $6.30 | $6.51 | 67.98K |
| Sep 8, 2026 | $6.20 | $6.76 | $6.20 | $6.34 | 105.87K |
| Sep 4, 2026 | $6.11 | $6.29 | $6.11 | $6.25 | 12K |
| Sep 3, 2026 | $6.19 | $6.345 | $6.095 | $6.105 | 18.87K |
| Sep 2, 2026 | $6.15 | $6.37 | $6.11 | $6.13 | 50.59K |
| Sep 1, 2026 | $6.19 | $6.4899 | $6.10 | $6.23 | 62.66K |
| Aug 31, 2026 | $6.28 | $6.38 | $6.0246 | $6.33 | 54.54K |
| Aug 28, 2026 | $6.00 | $6.625 | $5.86 | $6.355 | 112.94K |
| Aug 27, 2026 | $6.58 | $6.62 | $6.24 | $6.45 | 102.02K |
| Aug 26, 2026 | $6.83 | $6.84 | $6.50 | $6.61 | 53.83K |
| Aug 25, 2026 | $6.78 | $6.90 | $6.5701 | $6.84 | 38.99K |
| Aug 24, 2026 | $6.63 | $6.85 | $6.58 | $6.84 | 38.78K |
The latest Smart Investors Daily articles mentioning LFVN.
LFVN research
Company profile and research snapshot.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 28, 2026 | Lake Street | Hold | — |
| May 7, 2026 | Lake Street | Hold | — |
| Jan 14, 2025 | Craig-Hallum | Buy | — |
| Dec 19, 2024 | Lake Street | Buy | — |
No generated briefing is available yet.
Benzinga · Sep 15, 2026
Disclosed on September 14, Kristen Cunningham, Chief Sales Officer at Lifevantage (NASDAQ:LFVN), executed a substantial insider sell as per the latest SEC filing. What Happened: Cunningham's decision to sell 9,001
Yahoo · Aug 31, 2026
Revenue fell 23% as macroeconomic pressures weighed on orders and average order sizes.
Yahoo · Aug 28, 2026
Moby summary of LifeVantage Corporation's Q4 2026 earnings call
Benzinga · Aug 28, 2026
Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LFVN.
